Compare Enveric Biosciences Inc (ENVB) vs Personalis Inc. Common Stock (PSNL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Personalis Inc. Common Stock — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $6.09M), while Personalis Inc. Common Stock trades at $15.95 (market cap $1.70B). The key difference: Personalis Inc. Common Stock is far larger — about 279.1× Enveric Biosciences Inc's market cap, and Personalis Inc. Common Stock is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Personalis Inc. Common Stock for 0 Days on average.
| ENVB | PSNL | |
|---|---|---|
Market Cap | $6.09M | $1.70B |
Volume | 163,910 | 3,262,398 |
Sector | Health | Health |
52-Week High | $10.80 | $18.38 |
52-Week Low | $1.27 | $5.04 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | -$2.21M | $1.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.40, down 4.76% on the day, with a bearish technical outlook from moving averages. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten EPS estimates in recent quarters. Recent news includes a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in an investment conference.
The outlook is mixed; analyst consensus is 75% buy with potential from its drug pipeline, but high financial losses and negative ROE/ROA pose significant risks. Investment opportunity hinges on clinical success, while near-term volatility and cash burn are key concerns for stockholders.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Personalis Inc. Common Stock
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →
